Literature DB >> 10933910

Free cholesterol enhances adenoviral vector gene transfer and expression in CAR-deficient cells.

S Worgall1, T S Worgall, K Kostarelos, R Singh, P L Leopold, N R Hackett, R G Crystal.   

Abstract

Efficient adenovirus vector-mediated gene transfer depends on the presence of sufficient amounts of the high-affinity coxsackie-adenovirus (Ad) receptor (CAR) on the surface of the target cell leading to receptor-mediated endocytosis of the vector. The present study evaluates the effect of free cholesterol, a lipid component of endocytic vesicles, on Ad uptake into CAR-deficient cells. Infection in the presence of free cholesterol at its maximum solubility in water led to increased binding, uptake, and expression of Ad in human skin fibroblasts and alveolar macrophages, two primary human cells known to be deficient in CAR. The effect of free cholesterol was maximal at its solubility maximum in aqueous solution. Increase of Ad vector-mediated gene transfer with cholesterol was dependent on the lack of CAR receptor expression on the surface and was diminished by overexpression of CAR in CAR-deficient cells. Cholesterol-mediated increase of Ad-mediated gene expression was dependent on coincubation of both cholesterol and Ad and was not dependent on the cholesterol content of the cell. Increased Ad vector-mediated gene expression in the presence of free cholesterol was also observed in murine skin in vivo. Structural analysis of the Ad-cholesterol mixture showed complexation between Ad particles leading to formation of multivirus aggregates due to hydrophobic interaction. The addition of free cholesterol with Ad vectors may be a simple way to increase Ad-mediated gene transfer to cells that are poor targets due to their lack of a sufficient number of Ad receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933910     DOI: 10.1006/mthe.1999.0013

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  7 in total

1.  Rapid assessment of adenovirus serum neutralizing antibody titer based on quantitative, morphometric evaluation of capsid binding and intracellular trafficking: population analysis of adenovirus capsid association with cells is predictive of adenovirus infectivity.

Authors:  T Vincent; B G Harvey; S M Hogan; C J Bailey; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Gene delivery by dendrimers operates via a cholesterol dependent pathway.

Authors:  Maria Manunta; Peng Hong Tan; Pervinder Sagoo; Kirk Kashefi; Andrew J T George
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

3.  Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.

Authors:  Shi-He Liu; Nancy Smyth-Templeton; Alan R Davis; Elizabeth A Davis; Nikiforos Ballian; Min Li; Hao Liu; William Fisher; F Charles Brunicardi
Journal:  Surgery       Date:  2011-02-05       Impact factor: 3.982

Review 4.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

5.  The expression of exogenous genes in macrophages: obstacles and opportunities.

Authors:  Xia Zhang; Justin P Edwards; David M Mosser
Journal:  Methods Mol Biol       Date:  2009

Review 6.  Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.

Authors:  Michael G Katz; Anthony S Fargnoli; Richard D Williams; Charles R Bridges
Journal:  Hum Gene Ther       Date:  2013-11       Impact factor: 5.695

7.  Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer.

Authors:  Soo-Yeon Kim; Sang-Jin Lee; Jin-Ki Kim; Han-Gon Choi; Soo-Jeong Lim
Journal:  Int J Nanomedicine       Date:  2017-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.